MONICA MCGEE: Open Payments
NPI 1588342570 · GULF BREEZE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $337 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Edwards Lifesciences Corporation | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $39 |
| Corium, LLC | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: INGREZZA, AIRSUPRA, LUMRYZ, Azstarys, XIFAXAN, Ozempic, MOUNJARO, Kerendia.
Industry payments across FL — which companies pay providers there.
